Allarity Therapeutics A/S: Financial statements 2014
CVR: 28106351
Source: annual report 2014, Danish Business Authority
01/01/2014 – 31/12/2014
Allarity Therapeutics A/S (CVR 28106351) has filed annual accounts for 2014. In 2014, the company reported revenue of DKK 4,315,459 and a net result of DKK -5,347,074 compared with DKK -3,539,007 the year before. That is an increase of 6.6% compared with the year before. The profit margin was -123.9%. Equity in the 2014 report amounted to DKK 22,219,208. The solvency ratio was 91%.
- Revenue
- DKK 4,315,459
- Gross Profit
- DKK -4,405,010
- Profit/Loss
- DKK -5,347,074
- Equity
- DKK 22,219,208
- Total Assets
- DKK 24,412,603
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2014 | 4.3M | -4.4M | -5.3M | 22.2M | - |
| 2013 | 4M | 184K | -3.5M | 10.4M | - |
| 2012 | 3.9M | 566K | -2.8M | 4.5M | - |
Official annual report
Screen every Danish company
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningEvents in 2014
Allarity Therapeutics A/S has published its annual report for 2013. Revenue came to DKK 4,049,607, and the net result was DKK -3,539,007.
As of April 24, 2014, Gunnar Magnus Severus Modée Persson has joined the board of directors of Allarity Therapeutics A/S.
About Allarity Therapeutics A/S
Allarity Therapeutics A/S was a Danish company of the type Aktieselskab based in Hørsholm, founded in 2004. The company has been dissolved on 16 October 2025. The company was registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The company was previously named ONCOLOGY VENTURE A/S and MEDICAL PROGNOSIS INSTITUTE A/S. The company has 6 employees (2021). In 2024, the company reported a gross profit of DKK -81,000 and a net result of DKK -83,000 compared with DKK -406,000 the year before. Equity in the 2024 report amounted to DKK 0.
